Pain control by targeting oxidized phospholipids: functions, mechanisms, perspectives

Within the lipidome oxidized phospholipids (OxPL) form a class of chemically highly reactive metabolites. OxPL are acutely produced in inflamed tissue and act as endogenous, pain-inducing metabolites. They excite sensory, nociceptive neurons by activating transient receptor potential ion channels, s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Oehler, Beatrice (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 25 January 2021
In: Frontiers in endocrinology
Year: 2021, Jahrgang: 11, Pages: 1-9
ISSN:1664-2392
DOI:10.3389/fendo.2020.613868
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3389/fendo.2020.613868
Verlag, lizenzpflichtig, Volltext: https://www.frontiersin.org/articles/10.3389/fendo.2020.613868/full
Volltext
Verfasserangaben:Beatrice Oehler, Alexander Brack, Robert Blum and Heike L. Rittner
Beschreibung
Zusammenfassung:Within the lipidome oxidized phospholipids (OxPL) form a class of chemically highly reactive metabolites. OxPL are acutely produced in inflamed tissue and act as endogenous, pain-inducing metabolites. They excite sensory, nociceptive neurons by activating transient receptor potential ion channels, specifically TRPA1 and TRPV1. Under inflammatory conditions, OxPL-mediated receptor potentials even potentiate the action potential firing rate of nociceptors. Targeting OxPL with D-4F peptide or antibodies like E06 can be used to control acute, inflammatory pain syndromes. The basics of how OxPL operate as agonists and excitants are not completely understood: Due to the difficulties to stabilize and measure these highly reactive metabolites in a physiological context, it is not yet clear, how OxPL contribute to the many functions of the epilipidome in vivo. With a focus on proalgesic specificities of OxPL, this article discusses, how targeting defined substances of the lipidome can contribute to mechanism-based therapies against primary and secondary chronic inflammatory or possibly also neuropathic pain.
Beschreibung:Gesehen am 01.12.2021
Beschreibung:Online Resource
ISSN:1664-2392
DOI:10.3389/fendo.2020.613868